Ff. Knapp et al., SITE-SPECIFIC STABLE RADIOIODINATION OF 1,2-PAL-3-IPPA - AN AGENT FORTHE POTENTIAL CLINICAL-EVALUATION OF PANCREATIC INSUFFICIENCY BY URINE ANALYSIS, The Journal of nuclear medicine, 34(6), 1993, pp. 946-952
To measure pancreatic lipase activity, we synthesized a triglyceride c
ontaining a radioiodinated fatty acid. The urinary excretion of radioa
ctivity was measured in five rats following administration of the agen
t by feeding tube. We attached 15-phenylpentadecanoic acid (PPA) to po
sition-3 of 1,2-dipalmitoyl-rac-glycerol (1,2-Pal) to form 1,2-Pal-3-P
PA. The 1,2-Pal-3-IPPA (expected lipase substrate) was prepared by the
thallation-iodide displacement method. In a dual-label study, the I-1
25-1,2-Pal-3-IPPA triglyceride was administered with the I-125-IPPA fr
ee acid to rats (n = 5) by oral gavage. Urine and feces were collected
daily and the tissue distribution of both tracers was evaluated over
a five-day period. A significant portion of the administered activity
was excreted in 24 hr in the urine (I-125 30.31% + 4.32%; I-131, 35.0%
+ 7.290%), which cochromatographed with hippuric acid by thin layer c
hromatography. Release of the acidic components from the conjugated ex
cretory products by acid hydrolysis of the urine provided the radioact
ive acidic metabolites. Analysis of the Folch extracts of fat samples
demonstrated that the radioactive components cochromatographed in the
triglyceride region. This agent appears useful for the evaluation of v
arious gastrointestinal diseases.